P1.01-84 High Basal Serum EGF Levels Predicts Response to CIMAvax-EGF, a Therapeutic Vaccine for Advanced NSCLC
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.640
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV